Evidence map›Paper›PMID 24531876›Full record

ReviewPediatric cardiology2014

Beyond a broken heart: circulatory dysfunction in the failing Fontan.

Makoto Mori, Alfredo J Aguirre, Robert W Elder, Ali Kashkouli, Alton Brad Farris, Ryan M Ford, Wendy M Book

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2016
    Trial
  2. Article
  3. Transcatheter fenestration in Fontan failure: Our clinical experience.Turk gogus kalp damar cerrahisi dergisi · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Increased extracellular volume in the liver of pediatric Fontan patients.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2019
    Article
  14. Article
  15. Article
  16. Single-center experience of hemodialysis in patients after Fontan palliation.International journal of cardiology. Heart & vasculature · 2018
    Article
  17. Review
  18. Where Is the "Optimal" Fontan Hemodynamics?Korean circulation journal · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Makoto MoriDivision of Cardiology, Emory University School of Medicine, 1365 Clifton Road, NE, Bldg A - Suite 2447, Atlanta, GA, 30322, USA.
Alfredo J Aguirre
Robert W Elder
Ali Kashkouli
Alton Brad Farris
Ryan M Ford
Wendy M Book

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of ventricular dysfunction in late morbidity and mortality of univentricular hearts has been described previously. However, a significant proportion of adult Fontan patients who die or require heart transplantation do so with preserved ventricular function. The clinical deterioration in patients who have undergone Fontan palliation requires a broader view of circulatory dysfunction, one that takes into account the complex interaction of regulatory systems affecting hepatic, renal, and pulmonary blood flow, in addition to cardiac function. This review focuses primarily on the pathophysiology of multiple organ involvement in this circulatory dysfunction, with particular focus on the consequences of hepatic dysfunction and portal hypertension. The authors discuss hepatic perfusion, both in health and disease, and review the current understanding of liver histopathology and liver disease in adult Fontan patients and similar clinicopathologic states. They compare and contrast features of postsinusoidal portal hypertension with more typical adult cirrhotic disease. Finally, they delineate the related effects of portal hypertensive physiology on the systemic and pulmonary vasculature, the kidney, and the heart itself and discuss how these changes affect the care of the adult Fontan patient.

Indexed as

Heart VentriclesHypertension, PortalAdultFontan ProcedureGlobal HealthHeart Defects, CongenitalHemodynamicsHumansIncidenceSurvival RateTreatment Failure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.